Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group-Reference-Cited by-同舟云学术

Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group

Published:2023-05 Issue: Volume:Volume 14 Page:153-169
ISSN:1179-271X
Container-title:Patient Related Outcome Measures
language:en
Short-container-title:PROM

Author:

Rizio Avery A^ORCID,White Michelle K^ORCID,D’Souza Anita,Hsu Kristen,Schmitt Paula^ORCID,Quock Tiffany P^ORCID,Signorovitch James,Lousada Isabelle,Sanchorawala Vaishali^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference38 articles.

1. Systemic immunoglobulin light chain amyloidosis

2. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

3. Epidemiology of AL amyloidosis: a real-world study using US claims data

4. AL Amyloidosis

5. A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry–Verified Typing

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional Status and Quality of Life in Light-Chain Amyloidosis;JACC: Heart Failure;2024-09

2. Autologous stem cell transplantation in AL amyloidosis: Muddy waters;Blood Reviews;2024-08

3. Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis;Kidney International Reports;2024-07

4. The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review;Blood Advances;2024-06-28

5. Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings;Advances in Therapy;2024-06-04